Information  X 
Enter a valid email address

GlaxoSmithKline PLC (GSK)

  Print      Mail a friend       Annual reports

Tuesday 02 May, 2017

GlaxoSmithKline PLC

Director/PDMR Shareholding

RNS Number : 9177D
GlaxoSmithKline PLC
02 May 2017
 

GlaxoSmithKline plc (the 'Company')

 

Transaction notification

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms C Thomas

b)

Position/status

SVP, Human Resources

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882

b)

Nature of the transaction

The exercise of a nil-cost option over Ordinary Shares granted on 20 March 2014 and, as previously announced, was adjusted for performance and vested on 20 March 2017 under the Company's 2009 Deferred Annual Bonus Plan- Matching Award associated with a post-tax bonus deferral.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

 

 

£0.0000

989

 

 

 

 

 

d)

Aggregated information

n/a single transaction

Aggregated volume Price

 

e)

Date of the transaction

2017-04-28

f)

Place of the transaction

 

n/a

 

 

 

 

 

 

 

 

1.

Details of PDMR/person closely associated with them ('PCA')

a)

Name

Ms C Thomas

b)

Position/status

SVP, Human Resources

c)

Initial notification/

amendment

Initial Notification

2.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

GlaxoSmithKline plc

b)

LEI

5493000HZTVUYLO1D793

3.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted

a)

Description of the financial  instrument

Ordinary shares of 25 pence each ('Ordinary Shares')

 

ISIN: GB0009252882 

b)

Nature of the transaction

The sale of Ordinary Shares to meet tax liabilities on a nil-cost option over Ordinary Shares exercised on 28 April 2017 under the Company's Deferred Annual Bonus Plan - Matching Award associated with a post-tax bonus deferral.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

 

 

£15.5450

467

 

 

 

 

 

d)

Aggregated information

n/a single transaction

Aggregated volume Price

 

e)

Date of the transaction

2017-04-28

f)

Place of the transaction

 

London Stock Exchange (XLON)

 

 

 

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLLFBDEFBBBF

a d v e r t i s e m e n t